HIV Prevention, Care and Treatment

CDC DRC is aligned to the 90-90-90 UNAIDS global goal aiming at reaching by 2020 90% of people living with HIV diagnosed, 90% of HIV diagnosed on antiretroviral treatment, and 90% of people in treatment with fully suppressed viral load. To attain this goal, CDC rolls out activities in Kinshasa and Haut-Katanga in various areas:

  1. Prevention:
  • Index testing using Partner Notification Strategy and social and sexual network testing approach
  • Routine provider-initiated testing and counseling (PITC) using a HIV risk screening tool
  • Prevention of mother-to-child transmission (PMTCT) in compliance with option B+ strategy providing long-life ARV treatment to mothers and prophylaxis for exposed infants
  • Orphan and Vulnerable Children (OVC) Program implemented for a healthy, stable, safe and educated children. The OVC program also offers risk avoidance in girls and Gender Based violence prevention and respons
  • Key Population: provision of accessible, acceptable and friendly services to KPs through a standardized STI/HIV prevention, Care and Treatment package for those engaged in sex work and other risky behaviors
  • Sexual Gender-Based Violence (SGBV): provision of Post-Exposure prophylaxis to SGBV survivors
  • Waste management: supply of waste management facilities (incinerators and waste disposal materials) and injection safety supplies
  1. Care and Treatment:
  • Same day/rapid initiation of positives on ART as per the 2016 WHO “test and start” guidelines
  • Provision of Differentiated Service Delivery models for stable patients, including community-based ARV distribution models
  • TB/HIV integration lining up to the “ONE STOP SHOP” model: among PLHIV: 1) TB screening at each encounter, 2) Xpert for TB diagnostic evaluation, 3) Provision of Isoniazid Preventive Therapy, 4) TB Infection Control; Among TB: 1) HIV testing among presumptive and confirmed TB cases, 2) Provision of ART to TB/HIV+ patients
  • Retention and adherence support strategies aiming at achieving viral load (VL) suppression for all patients under treatment by the 6th month of treatment. These strategies also encompass the community-based activities such support groups
  • Management of patient with unsuppressed VL, and patient in advanced disease
  • Quality management and quality improvement through Site Improvement through Monitoring System (SIMS) tool. This tool measures compliance with global and national service standards and thus, identify areas for quality improvement and inform programmatic decisions.